Barclays Initiates Coverage On Insulet with Equal-Weight Rating, Announces Price Target of $150

Barclays analyst Christopher Pasquale initiates coverage on Insulet (NASDAQ:PODD) with a Equal-Weight rating and announces Price Target of $150.